More Business Wire
View Older Stories View Newer Stories-
AltynGold Plc ("AltynGold" or the "Company") Participation in MINEX Kazakhstan 2026
-
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations
-
Rio Tinto provides Iron Ore update following Tropical Cyclone Narelle
-
Infinitas Launches Aureon Capital to Open Private Markets to Public Investors
-
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The Company Wrapped up Its First Month of Robotics Deliveries as It Marches Forward Towards Its 200-unit Delivery Target for the
-
Faraday Future to Report Its Fourth Quarter and Full Year 2025 Financial Results and Host an Investor Call on March 31, 2026
-
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”
-
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyo
-
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension
-
CUPE congratulates Avi Lewis on becoming new leader of Canada's NDP
-
45th College Television Awards Winners Announced by Television Academy Foundation
-
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
-
Debevoise Secures Second Circuit Affirmance of Dismissal of $16 billion Claim Against YPF S.A.
-
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
-
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
-
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
-
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
-
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
-
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Sess
-
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
-
Nicklaus Companies LLC Closes Sale of Business to Jack Nicklaus-Backed 20 Majors, LLC
-
Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report
-
Kolibri Global Energy Inc. Announces Director Nominees for Upcoming Shareholder Meeting
-
Rising Tides in the Deep Blue Decade: Los Angeles Launches a Bold New Era for the Blue Economy Workforce
-
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
-
GAO Report Strengthens Case for Congressional Action on CMMI
-
Foundation for the Development of Western Syria Warns of Dangerous Escalation Targeting the Christian Community in Syria and Threatening Civil Peace
-
UWMC Responds to Two Harbors Acquisition Deal
-
Magellan Aerospace Corporation Announces Financial Results
-
Retractable Technologies, Inc. Reports Results for 2025
-
Covalon Announces Grant of Deferred Share Units
-
The Fairholme Focused Income Fund Announces Dividend
-
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
-
ZIVO Bioscience Provides Special Letter to Shareholders
-
Origin Materials, Inc. Reports Operating and Financial Results for Fourth Quarter and Full Year 2025
-
Liberty All-Star® Growth Fund, Inc. Announces Investment Manager Change
-
Arverne Group: ORANE Issuance Plan of a Minimum Amount of €33 Million, Intended to Be Primarily Subscribed by Bpifrance, Together With Longstanding Investors Eiffel Essentiel, ADEME Investissement
-
Virtus Total Return Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
CBL Properties Closes $176 Million Non-Recourse Financing
-
HAFNIA LIMITED: Cancellation of Treasury Shares
-
Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices
-
Core & Main Announces Changes to Board of Directors and Executive Chair
-
Verde Clean Fuels, Inc. Reports Q4 and FY 2025 Results
-
Virtus Artificial Intelligence & Technology Opportunities Fund Discloses Sources of Distribution – Section 19(a) Notice
-
indie Announces New Employee Inducement Grants
-
Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice
-
KBRA Releases Research – Private Credit: Deep Dive on AI and Software
-
Fastenal Company Announces Conference Call to Review 2026 First Quarter Earnings
-
Immersion Corporation Receives Nasdaq Staff Additional Delinquency Notice
-
Quanterix Corporation Announces Date of 2026 Annual Meeting
